Branislav Bystricky

Trencin, TC, Slovakia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Survival outcomes and prognostic value of nutritional and inflammatory markers in third-line treatment of metastatic pancreatic cancer.

Survival outcomes and prognostic value of nutritional and inflammatory markers in third-line treatment of metastatic pancreatic cancer.

Journal: Frontiers in oncology

Published: September 25, 2025

The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer-CEEGOG OX-01 Study.

The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer-CEEGOG OX-01 Study.

Journal: Cancers

Published: September 17, 2024

Pancreatic cancer - epidemiology, risk factors, nutritional and infl ammatory prognostic and predictive factors.

Pancreatic cancer - epidemiology, risk factors, nutritional and infl ammatory prognostic and predictive factors.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 22, 2024

The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group.

The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group.

Journal: Frontiers in oncology

Published: May 26, 2024

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients.

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients.

Journal: Frontiers in oncology

Published: February 17, 2023

Optimal dose of silymarin for the management of drug‑induced liver injury in oncology.

Optimal dose of silymarin for the management of drug‑induced liver injury in oncology.

Journal: Molecular and clinical oncology

Published: October 26, 2022

Spontaneous Regression of Merkel Cell Carcinoma: Case Report.

Spontaneous Regression of Merkel Cell Carcinoma: Case Report.

Journal: International medical case reports journal

Published: July 23, 2021

Quality of life and ability to work in ovarian cancer patients in Slovakia.

Quality of life and ability to work in ovarian cancer patients in Slovakia.

Journal: Neoplasma

Published: April 01, 2019

Hypotension as a symptom of autonomic neuropathy in patients with advanced malignancies.

Hypotension as a symptom of autonomic neuropathy in patients with advanced malignancies.

Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

Published: July 04, 2018

Global cancer control: responding to the growing burden, rising costs and inequalities in access.

Global cancer control: responding to the growing burden, rising costs and inequalities in access.

Journal: ESMO open

Published: October 05, 2017

Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.

Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.

Journal: Anticancer research

Published: March 21, 2017

Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer.

Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer.

Journal: Anticancer research

Published: February 18, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026